THYBETAXOR Trademark

Trademark Overview


On Friday, October 11, 2024, a trademark application was filed for THYBETAXOR with the United States Patent and Trademark Office. The USPTO has given the THYBETAXOR trademark a serial number of 79409214. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, October 21, 2025. This trademark is owned by Cascade Pharmaceuticals, Inc. The THYBETAXOR trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes for the treatment of inflammatory, metabolic, and immune system related diseases and disorders; diagnostic preparations for medical purposes; drugs for medical purposes, namely, pharmaceutical drug preparations for the prevention and treatment of inflammatory, metabolic, and immune system related diseases and disorders; bacteriological preparations for medical and veterinary use; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; chemical preparations for medical purposes, being pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the immune system, digestive system, and metabolic system; opotherapy preparations; biological preparations for medical purposes, being pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the immune system, digestive system, and metabolic system; medicine cases, portable, filled in t...
thybetaxor

General Information


Serial Number79409214
Word MarkTHYBETAXOR
Filing DateFriday, October 11, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, October 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 21, 2025

Trademark Statements


Goods and ServicesMedicines for human purposes for the treatment of inflammatory, metabolic, and immune system related diseases and disorders; diagnostic preparations for medical purposes; drugs for medical purposes, namely, pharmaceutical drug preparations for the prevention and treatment of inflammatory, metabolic, and immune system related diseases and disorders; bacteriological preparations for medical and veterinary use; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; chemical preparations for medical purposes, being pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the immune system, digestive system, and metabolic system; opotherapy preparations; biological preparations for medical purposes, being pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the immune system, digestive system, and metabolic system; medicine cases, portable, filled in the nature of containers for medical use sold filled with a platelet additive solution; stem cells for medical purposes; chemical reagents for medical or veterinary purposes;

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCascade Pharmaceuticals, Inc
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameCascade Pharmaceuticals, Inc
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Thursday, November 14, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 15, 2024APPLICATION FILING RECEIPT MAILED
Friday, March 21, 2025ASSIGNED TO EXAMINER
Saturday, April 5, 2025NON-FINAL ACTION WRITTEN
Sunday, April 6, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 9, 2025REFUSAL PROCESSED BY MPU
Monday, June 9, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, June 27, 2025REFUSAL PROCESSED BY IB
Friday, July 25, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 25, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 25, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 25, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 22, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 22, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 19, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 15, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 21, 2025PUBLISHED FOR OPPOSITION
Tuesday, October 21, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED